$AET (Aetna Inc.)

$AET {{ '2017-05-02T10:25:16+0000' | timeago}} • Announcement

$AET slipped to a loss in 1Q17 from a profit last year, due to costs associated with the termination of $HUM merger agreement. Net loss was $381MM or $1.11 per share compared to a profit of $737MM or $2.08 per share last year. Revenue declined 3% to $15.17Bil. Adjusted EPS increased to $2.71 from $2.32.

$CVS {{ '2017-11-06T18:20:05+0000' | timeago}} • Announcement

$CVS, that proposed to buy $AET, reported a 17% drop in its 3Q17 profit, mainly due to reimbursement pressure and $187MM of losses on pension settlements. Net income during the quarter fell to $1.28Bil, or $1.26 per share, from $1.54Bil, or $1.44 per share during 3Q16. Adj. EPS was $1.50, down 9%. Revenues rose 4% YoY to $46.2Bil.

$AET {{ '2017-10-31T22:01:28+0000' | timeago}} • Infographic

$AET Aetna Earnings AlphaGraphic: Q3 2017 Highlights

$AET {{ '2017-09-29T18:44:40+0000' | timeago}} • Announcement

The BoD of $AET has declared a quarterly cash dividend of $0.50 per share on the company’s common stock. The dividend is payable on Oct 27, 2017, to shareholders of record as on Oct 12, 2017.

$AET {{ '2017-08-10T19:48:55+0000' | timeago}} • Announcement

$AET, a healthcare company, has informed that it has completed a public offering of $1Bil of 3.875% senior notes due in 2047. It intends to use the proceeds to repay a portion of its 1.5% senior notes and floating-rate senior notes, both due in 2017, and for general corporate purposes.

$AET {{ '2017-08-03T14:51:51+0000' | timeago}} • Webcast

$AET stated that in terms of its Group Medicare Advantage business, the company is optimistic on achieving strong results in 2018. This is based on positive trends in implementation, a robust pipeline and further opportunities for geographic expansion and entering new markets.

$AET {{ '2017-08-03T14:29:09+0000' | timeago}} • Webcast

$AET's Medicare business performed well during 2Q17 generating strong premium growth and profitability metrics. The company’s individual Medicare Advantage products continue to be the primary driver of growth with 14% YTD membership growth, nearly a third of which is due to geographic expansion.

$AET {{ '2017-08-03T14:24:43+0000' | timeago}} • Webcast

$AET posted total revenue of $14.8Bil for its Health Care segment in 2Q17, down from $15.2Bil in 2Q16. Total revenue in the Group Insurance segment was $642MM versus $647MM in 2Q16. In the Large Case Pension segment, total revenue was $81MM compared with $82MM for 2Q16.

$AET {{ '2017-08-03T13:38:09+0000' | timeago}} • Infographic

$AET Aetna Inc Earnings AlphaGraphic: Q2 2017 Highlights

$AET {{ '2017-08-03T12:46:02+0000' | timeago}} • Announcement

For full-year 2017, $AET expects GAAP EPS to be $5.46-5.56 and adjusted EPS to be $9.45-9.55.

$AET {{ '2017-08-03T12:43:05+0000' | timeago}} • Announcement

$AET posted total revenue of $15.5Bil for 2Q17, down 3% from 2Q16. The decrease in total revenue was primarily due to lower premiums in the Health Care segment, including lower membership in ACA compliant individual and small group products, and the temporary suspension of the health insurer fee (HIF) in 2017.

$AET {{ '2017-08-03T12:38:04+0000' | timeago}} • Announcement

$AET reported a 52% increase in 2Q17 earnings. Net income was $1.2Bil or $3.60 per share compared to $791MM or $2.23 per share in 2Q16. The increase in net income was primarily due to the increase in adjusted earnings and lower transaction and integration-related costs. Adjusted earnings were $1.1Bil or $3.42 per share in 2Q17.

$AET {{ '2017-06-21T16:20:19+0000' | timeago}} • Announcement

Healthcare company $AET has signed a collaborative agreement with Community Care Physician Network (CCPN) to develop innovative ways to transform healthcare delivery in North Carolina. As per the deal, Aetna will combine its expertise in alternative value-based delivery models with the advanced medical homes of CCPN physicians, from January 2018.

$AET {{ '2017-05-19T20:29:18+0000' | timeago}} • Announcement

$AET's BoD declared a quarterly cash dividend of $0.50 per share on its common stock. The dividend is payable on July 28, 2017, to shareholders of record at the close of business on July 13, 2017.

$AET {{ '2017-05-02T18:41:05+0000' | timeago}} • Webcast

$AET said there are some developments and conversations underway around its Medicare product as well as its Commercial product, as Aetna gets closer to the Jan 1, 2020 renewal date of the CVS relationship.

$AET {{ '2017-05-02T18:35:35+0000' | timeago}} • Webcast

Even as $AET said it won't provide FY18 guidance, the company continues to see that it will exceed industry growth, especially into January of 2018. Aetna sees fair amount of activity for the 7/1 selling season, and continues to remain focused on national accounts for 2018 as well.

$AET {{ '2017-05-02T18:31:53+0000' | timeago}} • Webcast

$AET, as it posted 1Q17 results, said it plans to continue same-store growth by opening new stores where the company saw a fairly sizable portion of new enrollment in the year. Aetna plans to add more geographies and continue to invest in Star ratings, particularly around service and CAPs in each local market.

$AET {{ '2017-05-02T14:02:27+0000' | timeago}} • Webcast

When asked whether the partnership with $AET will restrict $CVS taking on other large health plans, $CVS commented that currently it services more than 70 health plans. $CVS added that there are some exciting opportunities with $AET's partnership.

$AET {{ '2017-05-02T10:26:20+0000' | timeago}} • Announcement

$AET's adjusted earnings for 1Q17 increased to $939MM from $821MM a year ago. The double-digit percentage increase in adjusted earnings was primarily due to strong performance in the company's Health Care segment, despite the continued pressure in $AET's individual Commercial products.

$AET {{ '2017-05-02T10:26:05+0000' | timeago}} • Announcement

$AET's revenue for 1Q17 decreased by 3% from last year and adjusted revenue declined by 1%. The decrease was primarily due to lower premiums in $AET's Health Care segment, including lower membership in ACA compliant individual and small group products and the temporary suspension of the HIF in 2017.

$AET {{ '2017-05-02T10:25:16+0000' | timeago}} • Announcement

$AET slipped to a loss in 1Q17 from a profit last year, due to costs associated with the termination of $HUM merger agreement. Net loss was $381MM or $1.11 per share compared to a profit of $737MM or $2.08 per share last year. Revenue declined 3% to $15.17Bil. Adjusted EPS increased to $2.71 from $2.32.

Recent Transcripts

PDCO (Patterson Companies, Inc.)
Tuesday, November 21 2017 - 3:00pm
MDT (Medtronic plc)
Tuesday, November 21 2017 - 1:00pm
OPK (Opko Health, Inc.)
Wednesday, November 8 2017 - 9:30pm
VRML (Vermillion, Inc.)
Wednesday, November 8 2017 - 9:30pm
HUM (Humana Inc.)
Wednesday, November 8 2017 - 2:00pm
ATRS (Antares Pharma Inc.)
Tuesday, November 7 2017 - 1:30pm
VRX (Valeant Pharmaceuticals International, Inc.)
Tuesday, November 7 2017 - 1:00pm
MOH (Molina Healthcare, Inc.)
Thursday, November 2 2017 - 9:00pm
ALL (The Allstate Corporation)
Thursday, November 2 2017 - 1:00pm
BLUE (bluebird bio, Inc.)
Wednesday, November 1 2017 - 12:30pm
OMI (Owens & Minor Inc.)
Wednesday, November 1 2017 - 12:00pm
PFE (Pfizer Inc.)
Tuesday, October 31 2017 - 2:00pm
WCG (WellCare Health Plans, Inc.)
Tuesday, October 31 2017 - 1:30pm
AET (Aetna Inc.)
Tuesday, October 31 2017 - 12:30pm
MSFT (Microsoft Corporation)
Thursday, October 26 2017 - 9:30pm
TVTY (Tivity Health, Inc.)
Thursday, October 26 2017 - 9:00pm
GOOGL (Alphabet Inc.)
Thursday, October 26 2017 - 8:30pm
AMGN (Amgen Inc)
Wednesday, October 25 2017 - 9:00pm
LH (Laboratory Corp. of America Holdings)
Wednesday, October 25 2017 - 1:00pm
LLY (Eli Lilly and Company)
Tuesday, October 24 2017 - 1:00pm

AlphaGraphics you may like